Pliant Therapeutics, Inc.
PLRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $94 | $87 | $92 | $71 |
| Short-Term Investments | $148 | $176 | $214 | $285 |
| Receivables | $0 | $2 | $2 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $4 | $4 |
| Total Curr. Assets | $246 | $267 | $311 | $362 |
| Property Plant & Equip (Net) | $29 | $31 | $32 | $33 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $31 | $32 | $34 | $35 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $277 | $300 | $345 | $397 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $6 | $6 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $18 | $22 | $27 |
| Total Curr. Liab. | $18 | $21 | $28 | $33 |
| LT Debt | $59 | $59 | $59 | $60 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $59 | $59 | $59 | $60 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $29 | $30 | $30 | $30 |
| Total Liabilities | $76 | $80 | $88 | $93 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$836 | -$810 | -$766 | -$710 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $1,036 | $1,030 | $1,023 | $1,014 |
| Total Equity | $200 | $220 | $257 | $304 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $277 | $300 | $345 | $397 |
| Net Debt | -$34 | -$26 | -$32 | -$11 |